Connection
Liron Caplan to Randomized Controlled Trials as Topic
This is a "connection" page, showing publications Liron Caplan has written about Randomized Controlled Trials as Topic.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.348 |
|
|
|
-
Sen R, Caplan L. Current treatment and molecular targets for axial spondyloarthritis: Evidence from randomized controlled trials. Curr Opin Pharmacol. 2022 12; 67:102307.
Score: 0.143
-
Maksymowych WP, Lambert RGW, Caplan L, van den Bosch FE, ?stergaard M. Improving the design of RCTs in non-radiographic axial spondyloarthritis. Nat Rev Rheumatol. 2022 08; 18(8):481-489.
Score: 0.139
-
Caplan L, Saag KG. Glucocorticoids and the risk of osteoporosis. Expert Opin Drug Saf. 2009 Jan; 8(1):33-47.
Score: 0.055
-
Wolfe F, Caplan L, Michaud K. Measuring the efficacy and effectiveness of rheumatoid arthritis therapy: time to change our thinking and adopt a new model. J Rheumatol. 2004 Dec; 31(12):2317-9.
Score: 0.010